RRM2 and familial pancreatic carcinoma: Mutations in ANLN, ASPM, CDK1, CENPF, CEP55, DTL, ETC2, NEK2, TOP2A and PRC1 affect overall survival and disease-free survival in pancreatic cancer, whereas mutations in RRM2 and ZWINT affect disease-free survival.